Threshold primary tumour sizes for nodal and distant metastases in papillary and follicular thyroid cancers

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 6, 2012, Pages 2473-2476

  Uz Zaman, Maseeh ^a   Fatima, Nosheen ^b   Sajjad, Zafar ^a   Akhtar, Jaweed ^a   Islam, Najmul ^a   Masood, Qamar ^a   Ahmed, Asma ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b Karachi Institute of Radiotherapy & Nuclear Medicine   (Pakistan)

Author keywords

Follicular; Metastasis; Papillary; Thyroid cancer; Tumour size

Indexed keywords

EID: 84874070504     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.6.2473     Document Type: Article

References (17)

1. Asari R, Koperek O, Scheuba C, et al. (2009). Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Ann Surg, 249, 1023-31.
2. Cerutti JM, Delcelo R, Amadei MJ, (2004). A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest, 113, 1234-42.
3. Coburn MC, Wanebo HJ, (1992). Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Sur, 164, 671-6.
4. Cooper DS, Doherty GM, Haugen BR, et al. (2009). Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19, 1167-214.
5. DeGroot LJ, Kaplan EL, McCormick M, et al. (1990). Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab, 71, 414-24.
6. Durante C, Haddy N, Baudin E, et al. (2006). Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endo Metab, 91, 2892-9.
7. Franceschi S, La Vecchia. (1994). Thyroid Cancer. Cancer Surv, 19/20, 393-422.
8. Grebe SK, Hay ID. (1996). Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am, 5, 43-63.
9. Hölzer S, Reiners C, Mann K, et al. (2000). For the U.S. and German Thyroid Cancer Group. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. Cancer, 89, 192-201.
10. Hundahl SA, Cady B, Cunningham MP, et al. (2000). For the U.S. and German Thyroid Cancer Study Group. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. An American College of Surgeons Commission on Cancer Patient Care Evaluation Study. Cancer, 89, 202-17.
11. Machens A, Holzhausen HJ, Dralle H. (2005). The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer, 103, 2269-73.
12. Mazzaferri EL, Jhiang SM. (1994). Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med, 97, 418-28.
13. Schlumberger MJ, (1998). Papillary and follicular thyroid cancer. NEJM, 1338, 297-306.
14. Shaha AR, (1998). Management of the neck in thyroid cancer. Otolaryngol Clin North Am, 31,823-31.
15. Shaha AR, Shah JP, Loree TR, (1997). Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg, 174, 474-6.
16. Shoup M, Stojadinovic A, Nissan A, et al. (2003). Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg, 197, 191-7.
17. Sobin LH, Wittekind C, editors (2002). TNM classification of malignant tumors. 6th edition. New York: John Wiley & Sons.